Scientific work

Prof. Dr. Mustafa Altınbaş

125 publications. The source of the information is stated next to each publication.

Back to profile

  1. Remnant cholesterol inflammatory index for predicting pathological complete response to neoadjuvant therapy in breast cancer: A multicenter external validation study

    The Breast, 2026

    DOI 10.1016/j.breast.2026.104936 PMID 42777557 Open-access full textSource: ORCID

  2. Predicting Pathologic Response in Locally Advanced Rectal Cancer Using Inflammatory, Nutritional, and Sarcopenia-Based Markers: A Regression and AI-Based Analysis (CINR-AI Study)

    Clinical Colorectal Cancer, 2026

    DOI 10.1016/j.clcc.2025.10.002 PMID 41198426 1 citation (Europe PMC) Source: ORCID

  3. Real-world outcomes of ribociclib treatment in HR-positive/HER2-negative metastatic breast cancer: efficacy, safety, and prognostic factors

    Expert review of anticancer therapy, 2026

    DOI 10.1080/14737140.2026.2733826 PMID 42733172 Source: Europe PMC

  4. Baseline 25-hydroxyvitamin D and progression-free survival in de novo metastatic hormone-sensitive prostate cancer: prognostic model development and external validation

    The oncologist, 2026

    DOI 10.1093/oncolo/oyag396 PMID 42836684 Open-access full textSource: Europe PMC

  5. Impact of Prior mRNA COVID-19 Vaccination on PFS2 in NSCLC Patients Receiving Second-Line Immune Checkpoint Inhibitors: A Real-World Analysis

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15072475 PMID 41976774 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  6. Recurrence of gastric cancer with Krukenberg tumor, presenting with a high alpha-fetoprotein level, a case report

    Frontiers in Oncology, 2026

    DOI 10.3389/fonc.2026.1676891 PMID 41800062 Open-access full textSource: OpenAlex

  7. Integrated assessment of cachexia, body composition, and patient-reported outcomes in unplanned hospitalizations of patients with metastatic cancer (PRO-HAND study).

    Journal of Clinical Oncology, 2026

    DOI 10.1200/jco.2026.44.16_suppl.12075 Source: OpenAlex

  8. Real-world outcomes of ribociclib treatment in HR-positive/HER2-negative metastatic breast cancer: efficacy, safety, and prognostic factors

    Figshare, 2026

    DOI 10.6084/m9.figshare.33717648 Open-access full textSource: OpenAlex

  9. Clinicopathologic Characteristics, Treatment Patterns, and Survival Outcomes in Malignant Mesothelioma: A Population-based SEER Study, 2004-2023

    Journal of Oncological Sciences, 2026

    DOI 10.37047/jos.galenos.2026.2026-8-2 Open-access full textSource: OpenAlex

  10. Prognostic value of the lymphocyte‑albumin‑neutrophil ratio in de novo metastatic colorectal cancer: A continuous‑variable analysis

    Oncology Letters, 2026

    DOI 10.3892/ol.2026.15922 Open-access full textSource: OpenAlex

  11. Prognostic utility of the C-reactive protein–albumin–lymphocyte (CALLY) index in metastatic renal cell carcinoma

    BMC Cancer, 2025

    DOI 10.1186/s12885-025-14767-9 PMID 40836295 10 citations (OpenAlex) Open-access full textSource: OpenAlex

  12. Prognostic value of the CALLY index in De Novo metastatic colorectal cancer: a retrospective study

    Anatolian Current Medical Journal, 2025

    DOI 10.38053/acmj.1725787 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  13. The results of adding immunotherapy to chemotherapy in patients with small cell lung cancer: Registurk-Lung study—Real-world data.

    Journal of Clinical Oncology, 2024

    DOI 10.1200/jco.2024.42.16_suppl.e20006 Open-access full textSource: OpenAlex

  14. Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

    BMC Cancer, 2023

    DOI 10.1186/s12885-023-10609-8 PMID 36765293 18 citations (Europe PMC) Open-access full textSource: OpenAlex

  15. The Incidental Diagnosis of Lung Cancer Through Chest Tomography During the COVID-19 Pandemic

    Journal of Oncological Sciences, 2023

    DOI 10.37047/jos.2023-98748 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  16. Hemoglobin, albumin, lymphocyte, and platelet score as a predictor of prognosis in metastatic gastric cancer

    World Journal of Gastrointestinal Oncology, 2023

    DOI 10.4251/wjgo.v15.i9.1626 PMID 37746652 32 citations (OpenAlex) Open-access full textSource: OpenAlex

  17. Neoadjuvan tedavi alan rektum kanseri hastalarında tedavi yanıtını predikte eden parametreler var mı?

    Turkish Journal of Clinics and Laboratory, 2023

    DOI 10.18663/tjcl.1218737 Open-access full textSource: OpenAlex

  18. Investigation of BRCA2 Gene K3326X Variant in Patients with Breast and Ovarian Cancer by Next-Generation Sequencing Technique

    Acta Oncologica Turcica, 2023

    DOI 10.5505/aot.2023.68815 Open-access full textSource: OpenAlex

  19. Erken evre mide kanserli hastalarda iskelet kas dansitesinin sağkalım üzerine etkisi

    Turkish Journal of Clinics and Laboratory, 2022

    DOI 10.18663/tjcl.1078240 Open-access full textSource: OpenAlex

  20. Trastuzumab ± Capecitabine Maintenance After the First-Line Treatment of HER2-Positive Advanced Gastric Cancer: Retrospective Observational Real-Life Data of Turkish Oncology Group

    Journal of Gastrointestinal Cancer, 2021

    DOI 10.1007/s12029-021-00594-1 PMID 33538958 4 citations (Europe PMC) Source: OpenAlex

  21. Immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy

    Future oncology (London, England), 2021

    DOI 10.2217/fon-2021-0597 PMID 34342517 28 citations (Europe PMC) Open-access full textSource: Europe PMC

  22. Satisfaction analysis of cancer patient, caregiver and nurse

    2021

    Source: OpenAlex

  23. BRCA1/2 normal meme kanserli kadınlarda genotip-fenotip ilişkisinin araştırılması: Türkiye'den tek merkez deneyimi

    Turkish Journal of Clinics and Laboratory, 2021

    DOI 10.18663/tjcl.948240 Open-access full textSource: OpenAlex

  24. Combination of trastuzumab and taxane-containing intensified chemotherapy in first-line treatment of HER2-positive advanced gastric cancer

    Tumori Journal, 2020

    DOI 10.1177/0300891620969823 PMID 33167790 4 citations (Europe PMC) Source: OpenAlex

  25. Predictors of Neoplasia in Colonic Wall Thickening Detected via Computerized Tomography.

    Cureus, 2020

    DOI 10.7759/cureus.10553 PMID 32968607 2 citations (Europe PMC) Open-access full textSource: ORCID

  26. Hypertrichosis, trichomegaly, and androgenic alopecia related to cetuximab treatment.

    Journal of cancer research and therapeutics, 2020

    DOI 10.4103/jcrt.jcrt_343_17 PMID 32719294 5 citations (Europe PMC) Open-access full textSource: ORCID

  27. Tumor‐to‐tumor metastasis: Breast cancer metastasis to lung cancer

    The Breast Journal, 2020

    DOI 10.1111/tbj.13558 PMID 31565825 8 citations (Europe PMC) Open-access full textSource: ORCID

  28. Küçük hücreli akciğer kanserinde (KHAK) prognostik parametre olarak nötrofil, lenfosit, LDH ve NLO değerleri ile NLO’nun sağkalıma etkisi

    2020

    Source: OpenAlex

  29. The Prognostic Impact of the Neutrophil-Lymphocyte Ratio in Small-Cell Lung Cancer

    Acta Oncologica Turcica, 2020

    DOI 10.5505/aot.2020.49369 Open-access full textSource: OpenAlex

  30. A new prognostic index in patients with hormone receptor-positive and HER2-negative breast cancer,Nowy wskaźnik prognostyczny u pacjentek z rakiem piersi i ekspresja receptorów hormonalnych oraz brakiem ekspresji HER2

    Current Gynecologic Oncology, 2019

    DOI 10.15557/cgo.2019.0020 Open-access full textSource: ORCID

  31. Investigation of the severity of depressive symptoms in cancer patients receiving chemotherapy

    Eastern Journal of Medicine, 2019

    DOI 10.5505/ejm.2019.02419 Open-access full textSource: ORCID

  32. Mean platelet volume to lymphocyte ratio as a novel marker in patients with breast cancer who underwent curative resection,Stosunek sredniej objȩtosci plytek krwi do liczby limfocytów jako nowy marker u chorych na raka piersi po pierwotnym zabiegu operacyjnym

    Current Gynecologic Oncology, 2019

    DOI 10.15557/cgo.2019.0014 Open-access full textSource: ORCID

  33. Investigation of Clinical Features and the Use of Complementary and Alternative Medicines in Cancer Patients, A Single-Center Experience.

    Acta Oncologica Turcica, 2019

    DOI 10.5505/aot.2019.85579 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  34. "Squamos cell lung cancer" case applying with dyspepsia complaints

    Journal of Oncological Sciences, 2018

    DOI 10.1016/j.jons.2018.08.001 7 citations (OpenAlex) Open-access full textSource: ORCID

  35. The relationship between localization and neutrophil lymphocyte ratio in colon carcinoma

    Ortadoğu Tıp Dergisi, 2018

    DOI 10.21601/ortadogutipdergisi.398756 2 citations (OpenAlex) Open-access full textSource: ORCID

  36. Durable complete response with a short course of streptozotocin plus doxorubicin combination in malignant metastatic insulinoma

    Journal of Cancer Research and Therapeutics, 2018

    DOI 10.4103/0973-1482.188293 PMID 30197367 6 citations (OpenAlex) Open-access full textSource: OpenAlex

  37. Paraneoplastic Polycythemia Secondary to Testicular Mixed Germ Cell Tumor

    Akdeniz Medical Journal, 2018

    DOI 10.17954/amj.2018.115 Open-access full textSource: OpenAlex

  38. Mikst Germ Hücreli Testis Tümörüne İkincil Gelişen Paraneoplastik Polisitemi

    DergiPark (Istanbul University), 2018

    Open-access full textSource: OpenAlex

  39. Çoklu Primer Tümörler-Tek Merkez Deneyimi

    Dicle Medical Journal / Dicle Tip Dergisi, 2017

    DOI 10.5798/dicletip.362337 Open-access full textSource: OpenAlex

  40. Three-Year Disease-Free Survival After D2 Dissection and Liver Metastasectomy in a Gastric Cancer Case with Poor Prognostic Factors: A Case Report

    Akdeniz Medical Journal, 2017

    DOI 10.17954/amj.2017.70 Open-access full textSource: OpenAlex

  41. Abiraterone acetate as a possible cause of sudden cardiac death.

    PubMed, 2016

    PMID 27569102 1 citation (OpenAlex) Source: OpenAlex

  42. The Probable Relation Between Asbestos and Isolated Pleural Metastasis in Renal Cell Cancer

    Akdeniz Medical Journal, 2016

    DOI 10.17954/amj.2016.46 Source: OpenAlex

  43. Role of Cetuximab in Pharyngocutaneous Fistula Closure due To Peristomal Recurrence

    Journal of Case Reports, 2016

    DOI 10.17659/01.2016.0144 Open-access full textSource: OpenAlex

  44. Isolated inguinal lymph node metastasis in early stage testicular seminoma: a case report and review of the literature

    European journal of oncology, 2016

    Open-access full textSource: OpenAlex

  45. Akciğer Kanseri Tanılı Hastalarda İrritable Barsak Sendromu Sıklığı

    DergiPark (Istanbul University), 2016

    Open-access full textSource: OpenAlex

  46. Dramatic response to cetuximab and closure of pharyngocutaneous fistula due to peristomal recurrence

    AYBU AVESIS, 2016

    Source: OpenAlex

  47. Mide Kanserinde Tanı Anındaki Evre ile Patolojik Alt Tip ve Lokalizasyonun İlişkisi

    2015

    Source: OpenAlex

  48. Death Reasons and Factors That Affect on Survival of Cancer Patients

    Sakarya Medical Journal, 2015

    DOI 10.5505/sakaryamj.2015.33608 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  49. Krukenberg tumor presenting with amenorrhea as the sole initial symptom: Case report and review of the literature

    Journal of Cancer Research and Therapeutics, 2015

    DOI 10.4103/0973-1482.148679 PMID 26881586 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  50. Panitumumab as a Possible Cause of Hematospermia: What is the Mechanism?

    Future Oncology, 2015

    DOI 10.2217/fon.15.264 PMID 26562760 4 citations (OpenAlex) Source: OpenAlex